FDA Inspection 1048111 — Cedars-Sinai Medical Center

Cedars-Sinai Medical Center — FEI 2073862

The FDA completed an inspection of Cedars-Sinai Medical Center on February 27, 2018 in West Hollywood, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 27, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
West Hollywood, CA (United States)